ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669145 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669145; 2) Community: the network communities that were significantly associated with the response to NSC 669145; 3) Molecule: the relationships between components within communities and NSC 669145; 4) MDR: the compounds that were significantly associated with the NSC 669145.

NSC Compound Enrichment Correlation
NSC 683086 Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- 0.00396220821750022 0.47314229
NSC 684481 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 2-(3-chloro- phenyl)-5,6-dihydro-4-phenyl- 0.00396220821750022 -0.29654759
NSC 689735 Null 0.00396220821750022 0.47194421
NSC 714379 Null 0.00396220821750022 0.43596856
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.00396220821750022 0.38095204
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.00396220821750022 0.47931881
NSC 748715 Null 0.00396220821750022 0.32767458
NSC 758881 Orlistat (USAN) 0.00396220821750022 0.3566362
NSC 104942 EUPAROTIN 0.00396220821750027 0.60501337
NSC 176507 Fastigilin C 0.00396220821750027 0.71850505
Total:86  Current:13    [First] [Prev] [Next] [Last]